000			01921 a2200517 4500
005			20250513034755.0
264		0	_c19950911
008			199509s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1995.13.8.1950 _2doi
040			_aNLM _beng _cNLM
100	1		_aMotzer, R J
245	0	0	_aInterferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 1995
300			_a1950-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBlotting, Northern
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xpharmacology
650	0	4	_aIsotretinoin _xpharmacology
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aReceptors, Retinoic Acid _xmetabolism
650	0	4	_aRecombinant Proteins
650	0	4	_aRemission Induction
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aSchwartz, L
700	1		_aLaw, T M
700	1		_aMurphy, B A
700	1		_aHoffman, A D
700	1		_aAlbino, A P
700	1		_aVlamis, V
700	1		_aNanus, D M
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 13 _gno. 8 _gp. 1950-7
856	4	0	_uhttps://doi.org/10.1200/JCO.1995.13.8.1950 _zAvailable from publisher's website
999			_c7635970 _d7635970